Invicta Diagnostics, a diagnostic services provider under the brand name ‘PC Diagnostics’, announced its plans to achieve a revenue of Rs 60 crores by the financial year 2027. The company is planning to raise capital via an initial public offering (IPO) to finance its strategic expansion plans. It has appointed Socradamus Capital as the book running lead manager to the offer.
The Mumbai-headquartered company reported a total revenue of Rs 15.83 crore and a profit (PAT) of Rs 3.80 crore in FY24 based on Restated Consolidated Financial, compared with a total revenue of Rs 6.84 crore and a profit (PAT) of Rs. 0.23 crore in FY23 based on Restated Standalone Financial. The company is on track to achieve a total revenue of Rs 25 crores in FY2025.
Invicta operates a network of 8 diagnostic centres in Mumbai and its suburbs, in a hub-and-spoke model. It has a flagship centre located at Thane equipped to conduct all pathology specimens collection, basic and advanced radiology tests, three hubs located at Bhayandar, Byculla, and Marol, offering specialised services and supporting four satellite centres (spokes) in Lower Parel, Sewri, Mazgaon, and Kalwa. The company is planning to open 10 more diagnostic centres at strategic locations across Maharashtra in the next 12-18 months.
The company’s larger diagnostic centres (hubs) are equipped with advanced testing machinery, such as CT scans and MRIs, while smaller centres (spokes) offer basic tests such as sonography and X-rays. These spokes also function as sample collection centres for the company.
Speaking about the company’s plans, Rohit Prakash Srivastava, Promoter and CFO, Invicta Diagnostics, said, “We have made significant investments in hiring experienced radiologists and technicians to offer uncompromising services to our customers. Continuing our pursuit of excellence, we are exploring funding opportunities through an IPO to invest in advanced machinery and expansion plans to improve service quality.”